Características clínicas y epidemiológicas del síndrome inflamatorio multisistémico pediátrico relacionado a COVID19 en pacientes atendidos en Hospital Roberto Gilbert desde enero de 2020 hasta noviembre de 2022.

Abstract

Background: The pediatric multisystem inflammatory syndrome associated with COVID-19 consists of a series of clinical manifestations and requires certain laboratory criteria for diagnosis. It has been managed worldwide with various protocols based on studies conducted since its appearance. Therefore, this study was conducted to describe the clinical and epidemiological characteristics of the population of hospitalized patients during the specified period. Methodology: Descriptive-retrospective cross-sectional study. The sample consisted of 96 patients who met the inclusion criteria based on data collected from the medical records of hospitalized patients diagnosed with PIMS, and the analysis was performed using SPSS 25 and Excel. Results: Male prevalence (65.6%), age group 6-10 years (27.1%), mestizo race (96.9%), patients with eutrophic nutritional status (58.3%), hospitalization time 6-10 days, and fever duration predominated for less than 5 days from its onset (51%). Clinical manifestations were fever 100%, abdominal pain (64.6%), vomiting (56.3%), rash (55.2%), diarrhea (41.7%), shock (39.6%), conjunctival involvement (33.3%), respiratory symptoms (31.3%), lymphadenopathy (26%), oral mucosal involvement (21.9%), odynophagia (19.8%), headache (12.5%), altered consciousness (9.4%), and hand and foot swelling (6.3%). Complications: cardiac and renal abnormalities. Treatment: The use of corticosteroids in 80.2% of patients, enoxaparin 60.4%, and 22.9% required mechanical ventilation. The mortality rate was 2.1%.